UNICYCIVE THERAPEUTICS, INC. (UNCY) Free cash flow 2021–2025
UNICYCIVE THERAPEUTICS, INC. (UNCY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$31.3MFY2025 · since FY2021: -$5.8M → -$31.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.3M | -9.4% |
| FY2024 | -$28.6M | -56.6% |
| FY2023 | -$18.3M | -16.9% |
| FY2022 | -$15.7M | -170.1% |
| FY2021 | -$5.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More UNCY financial trends
UNCY RevenueUNCY Net incomeUNCY Net marginUNCY Gross profitUNCY Gross marginUNCY Operating incomeUNCY Operating marginUNCY Operating cash flowUNCY Capital expendituresUNCY Return on equityUNCY Stock buybacksUNCY Dividends paidUNCY Total assetsUNCY Total liabilitiesUNCY Shareholders’ equityUNCY overview →